| Mitomycin, ifosfamide, and cisplatin in unresectable non–small-cell lung cancer: Effects on survival and quality of life MH Cullen, LJ Billingham, CM Woodroffe, AD Chetiyawardana, ... Journal of Clinical Oncology 17 (10), 3188-3194, 1999 | 569 | 1999 |
| Carboplatin-or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data A Rossi, M Di Maio, P Chiodini, RM Rudd, H Okamoto, DV Skarlos, ... Journal of Clinical Oncology 30 (14), 1692-1698, 2012 | 563 | 2012 |
| Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial D Waller, MD Peake, RJ Stephens, NH Gower, R Milroy, MKB Parmar, ... European journal of cardio-thoracic surgery 26 (1), 173-182, 2004 | 505 | 2004 |
| Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes MA Beckles, SG Spiro, GL Colice, RM Rudd Chest 123 (1), 97S-104S, 2003 | 490 | 2003 |
| The physiologic evaluation of patients with lung cancer being considered for resectional surgery MA Beckles, SG Spiro, GL Colice, RM Rudd Chest 123 (1), 105S-114S, 2003 | 456 | 2003 |
| Cryptogenic fibrosing alveolitis: relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis RM Rudd, PL Haslam, M Turner-Warwick American Review of Respiratory Disease 124 (1), 1-8, 1981 | 427 | 1981 |
| Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes T Le Chevalier, G Scagliotti, R Natale, S Danson, R Rosell, R Stahel, ... Lung cancer 47 (1), 69-80, 2005 | 407 | 2005 |
| p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus. V Sundaresan, P Ganly, P Hasleton, R Rudd, G Sinha, NM Bleehen, ... Oncogene 7 (10), 1989-1997, 1992 | 378 | 1992 |
| Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial MF Muers, RJ Stephens, P Fisher, L Darlison, CMB Higgs, E Lowry, ... The Lancet 371 (9625), 1685-1694, 2008 | 346 | 2008 |
| British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Fibrosing Alveolitis Subcommittee of the Research Committee of … ID Johnston, RJ Prescott, JC Chalmers, RM Rudd Thorax 52 (1), 38-44, 1997 | 287 | 1997 |
| Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life SG Spiro, RM Rudd, RL Souhami, J Brown, DJ Fairlamb, NH Gower, ... Thorax 59 (10), 828-836, 2004 | 279 | 2004 |
| Phase II study of vinorelbine in patients with malignant pleural mesothelioma JPC Steele, J Shamash, MT Evans, NH Gower, MD Tischkowitz, RM Rudd Journal of clinical oncology 18 (23), 3912-3917, 2000 | 245 | 2000 |
| Five-day oral etoposide2 treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy RL Souhami, SG Spiro, RM Rudd, MCR Elvira, LE James, NH Gower, ... Journal of the National Cancer Institute 89 (8), 577-580, 1997 | 238 | 1997 |
| In vivo loss of expression of argininosuccinate synthetase in malignant pleural mesothelioma is a biomarker for susceptibility to arginine depletion PW Szlosarek, A Klabatsa, A Pallaska, M Sheaff, P Smith, T Crook, ... Clinical cancer research 12 (23), 7126-7131, 2006 | 228 | 2006 |
| Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical … SG Spiro, LE James, RM Rudd, CW Trask, JS Tobias, M Snee, D Gilligan, ... Journal of clinical oncology 24 (24), 3823-3830, 2006 | 219 | 2006 |
| First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial SM Lee, I Khan, S Upadhyay, C Lewanski, S Falk, G Skailes, E Marshall, ... The lancet oncology 13 (11), 1161-1170, 2012 | 215 | 2012 |
| The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesothelioma J Stebbing, T Powles, K McPherson, J Shamash, P Wells, MT Sheaff, ... Lung Cancer 63 (1), 94-97, 2009 | 193 | 2009 |
| Arginine deprivation with pegylated arginine deiminase in patients with argininosuccinate synthetase 1–deficient malignant pleural mesothelioma: a randomized clinical trial PW Szlosarek, JP Steele, L Nolan, D Gilligan, P Taylor, J Spicer, M Lind, ... JAMA oncology 3 (1), 58-66, 2017 | 192 | 2017 |
| Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: a phase III randomized study of the … RM Rudd, NH Gower, SG Spiro, TG Eisen, PG Harper, JAH Littler, ... Journal of Clinical Oncology 23 (1), 142-153, 2005 | 192 | 2005 |
| Anti-angiogenic therapy using thalidomide combined with chemotherapy in small cell lung cancer: a randomized, double-blind, placebo-controlled trial SM Lee, PJ Woll, R Rudd, D Ferry, M O'Brien, G Middleton, S Spiro, ... Journal of the National Cancer Institute 101 (15), 1049-1057, 2009 | 173 | 2009 |
